[1]
“Persistent Inadequate Disease Control and Therapeutic Inertia in Moderate-to-Severe Atopic Dermatitis: A 12-month Longitudinal Analysis of Real-world Outcomes from the TARGET-DERM AD registry”, J of Skin, vol. 8, no. 6, p. s462, Nov. 2024, doi: 10.25251/skin.8.supp.462.